U.S. FDA approves new HIV drug

WASHINGTON, Aug 12 (Reuters) – The U.S. Food and Drug Administration said on Monday it has approved GlaxoSmithKline Plc’s drug Tivicay to treat the most common strain of HIV, the virus that causes AIDS.

Common side effects of Tivicay in clinical trials included insomnia and headache. Serious side effects included allergic reactions and abnormal liver function in patients who were also infected with hepatitis B or C. Read more.

 YES, I AM A HUMAN AND NOT A ROBOT
  Checking the box is REQUIRED to unlock and proceed.